Literature DB >> 29706817

The PHACES syndrome: Multiple episodes of reproliferation of subglottic hemangioma.

Randall W Holdgraf1, Melissa Kress2.   

Abstract

Subglottic hemangioma is a potentially life-threatening manifestation of the PHACES syndrome. The disease process has been treated with corticosteroids, oral chemotherapeutic agents, endoscopic airway interventions, tracheostomy, and even laryngotracheal reconstruction. Oral propranolol has emerged as an effective therapy and in many cases has led to complete regression of hemangioma during the proliferative phase. There have been several reports of patients showing signs of reproliferation after discontinuing propranolol therapy. This article illustrates a patient who has had multiple episodes of reproliferation of subglottic hemangioma after weaning from propranolol therapy.

Entities:  

Keywords:  PHACES syndrome; propranolol; subglottic hemangioma

Year:  2018        PMID: 29706817      PMCID: PMC5914430          DOI: 10.1080/08998280.2017.1415547

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  Risk for PHACE syndrome in infants with large facial hemangiomas.

Authors:  Anita N Haggstrom; Maria C Garzon; Eulalia Baselga; Sarah L Chamlin; Ilona J Frieden; Kristen Holland; Sheilagh Maguiness; Anthony J Mancini; Catherine McCuaig; Denise W Metry; Kimberly Morel; Julie Powell; Susan M Perkins; Dawn Siegel; Beth A Drolet
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.

Authors:  Grecia V Vivas-Colmenares; Jose Bernabeu-Wittel; Veronica Alonso-Arroyo; Jose A Matute de Cardenas; Israel Fernandez-Pineda
Journal:  Pediatr Dermatol       Date:  2015-02-26       Impact factor: 1.588

3.  Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.

Authors:  Mai Thy Truong; Jonathan A Perkins; Anna H Messner; Kay W Chang
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-07-31       Impact factor: 1.675

Review 4.  Current knowledge of the pathogenesis of infantile hemangiomas.

Authors:  Thuy L Phung; Marcelo Hochman; Martin C Mihm
Journal:  Arch Facial Plast Surg       Date:  2005 Sep-Oct

5.  Recurrence of infantile hemangiomas treated with propranolol.

Authors:  Lorea Bagazgoitia; Angela Hernández-Martín; Antonio Torrelo
Journal:  Pediatr Dermatol       Date:  2011 Nov-Dec       Impact factor: 1.588

Review 6.  The biology and management of subglottic hemangioma: past, present, future.

Authors:  Reza Rahbar; Richard Nicollas; Gilles Roger; Jean-Michel Triglia; Erea-Noel Garabedian; Trevor J McGill; Gerald B Healy
Journal:  Laryngoscope       Date:  2004-11       Impact factor: 3.325

7.  Growth characteristics of infantile hemangiomas: implications for management.

Authors:  Linda C Chang; Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Sarah L Chamlin; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Anthony J Mancini; Denise W Metry; Amy J Nopper; Ilona J Frieden
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

8.  Consensus Statement on Diagnostic Criteria for PHACE Syndrome.

Authors:  Denise Metry; Geoffrey Heyer; Christopher Hess; Maria Garzon; Anita Haggstrom; Peter Frommelt; Denise Adams; Dawn Siegel; Karla Hall; Julie Powell; Ilona Frieden; Beth Drolet
Journal:  Pediatrics       Date:  2009-10-26       Impact factor: 7.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.